tirzepatide approved FDA Grants a New Indication for Obesity Management Zepbound® Vials (Tirzepatide) from $299/mo

No upfront cost pay only after your consultation and plan approval

In a recent study, participants who took tirzepatide lost an average of 12.4% of their body weight over 72 weeks

Over time, this, like other side effects associated with Tirzepatide, will improve (usually 2-4 weeks after a dose increase)

But when you are eating significantly less, it's easy to fall short on nutrients your teeth and gums actually need: calcium, vitamin D, vitamin C, phosphorus, and magnesium

Losing weight with tirzepatide feels like a turning point, until you see the price

Brand Zepbound Indication Obstructive sleep apnea Population Adults with moderate-to-severe OSA who also have obesity